Both the dermal tumors and RCC are characterized by high canonical mTORC1 activity and yet occur in the context of loss of heterozygosity (LOH), i.e., loss of FLCN-mediated activation of mTORC1. The gene discussed is FLCN; the disease is renal cell carcinoma.